Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.
Publication
, Journal Article
Wallentin, L; Becker, RC; Cannon, CP; Held, C; Himmelmann, A; Husted, S; James, SK; Katus, HS; Mahaffey, KW; Pieper, KS; Storey, RF; Steg, PG ...
Published in: International journal of cardiology
January 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
International journal of cardiology
DOI
EISSN
1874-1754
ISSN
0167-5273
Publication Date
January 2014
Volume
170
Issue
3
Start / End Page
e59 / e62
Related Subject Headings
- United States Food and Drug Administration
- Platelet Aggregation Inhibitors
- Humans
- Endpoint Determination
- Cardiovascular System & Hematology
- Adenosine
- Acute Coronary Syndrome
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wallentin, L., Becker, R. C., Cannon, C. P., Held, C., Himmelmann, A., Husted, S., … Harrington, R. A. (2014). Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International Journal of Cardiology, 170(3), e59–e62. https://doi.org/10.1016/j.ijcard.2013.11.003
Wallentin, Lars, Richard C. Becker, Christopher P. Cannon, Claes Held, Anders Himmelmann, Steen Husted, Stefan K. James, et al. “Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.” International Journal of Cardiology 170, no. 3 (January 2014): e59–62. https://doi.org/10.1016/j.ijcard.2013.11.003.
Wallentin L, Becker RC, Cannon CP, Held C, Himmelmann A, Husted S, et al. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International journal of cardiology. 2014 Jan;170(3):e59–62.
Wallentin, Lars, et al. “Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.” International Journal of Cardiology, vol. 170, no. 3, Jan. 2014, pp. e59–62. Epmc, doi:10.1016/j.ijcard.2013.11.003.
Wallentin L, Becker RC, Cannon CP, Held C, Himmelmann A, Husted S, James SK, Katus HS, Mahaffey KW, Pieper KS, Storey RF, Steg PG, Harrington RA. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International journal of cardiology. 2014 Jan;170(3):e59–e62.
Published In
International journal of cardiology
DOI
EISSN
1874-1754
ISSN
0167-5273
Publication Date
January 2014
Volume
170
Issue
3
Start / End Page
e59 / e62
Related Subject Headings
- United States Food and Drug Administration
- Platelet Aggregation Inhibitors
- Humans
- Endpoint Determination
- Cardiovascular System & Hematology
- Adenosine
- Acute Coronary Syndrome
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology